- Home
- RSSS vs TLSA Comparison
RSSS vs TLSA Comparison
Compare RSSS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- TLSA
- Stock Information
- Founded
- RSSS 2006
- TLSA 2013
- Country
- RSSS United States
- TLSA United Kingdom
- Employees
- RSSS N/A
- TLSA N/A
- Industry
- RSSS Business Services
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- TLSA Health Care
- Exchange
- RSSS Nasdaq
- TLSA Nasdaq
- Market Cap
- RSSS 86.4M
- TLSA 87.8M
- IPO Year
- RSSS N/A
- TLSA 2000
- Fundamental
- Price
- RSSS $2.68
- TLSA $1.20
- Analyst Decision
- RSSS Strong Buy
- TLSA
- Analyst Count
- RSSS 1
- TLSA 0
- Target Price
- RSSS $6.00
- TLSA N/A
- AVG Volume (30 Days)
- RSSS 30.4K
- TLSA 145.8K
- Earning Date
- RSSS 11-07-2024
- TLSA 05-10-2024
- Dividend Yield
- RSSS N/A
- TLSA N/A
- EPS Growth
- RSSS N/A
- TLSA N/A
- EPS
- RSSS N/A
- TLSA N/A
- Revenue
- RSSS $44,623,899.00
- TLSA N/A
- Revenue This Year
- RSSS $13.76
- TLSA N/A
- Revenue Next Year
- RSSS $9.92
- TLSA N/A
- P/E Ratio
- RSSS N/A
- TLSA N/A
- Revenue Growth
- RSSS 18.35
- TLSA N/A
- 52 Week Low
- RSSS $2.21
- TLSA $0.41
- 52 Week High
- RSSS $3.50
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- RSSS 50.43
- TLSA 65.44
- Support Level
- RSSS $2.55
- TLSA $0.83
- Resistance Level
- RSSS $2.75
- TLSA $0.92
- Average True Range (ATR)
- RSSS 0.10
- TLSA 0.09
- MACD
- RSSS -0.00
- TLSA 0.03
- Stochastic Oscillator
- RSSS 53.57
- TLSA 84.52
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.